Simultaneous Activation of Mu and Delta Opioid Receptors Reduces Allodynia and Astrocytic Connexin 43 in an Animal Model of Neuropathic Pain

Nunzio Vicario, Lorella Pasquinucci, Federica M. Spitale, Santina Chiechio, Rita Turnaturi, Filippo Caraci, Daniele Tibullo, Roberto Avola, Rosario Gulino, Rosalba Parenti, Carmela Parenti

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Neuropathic pain is a chronic condition triggered by lesions to the somatosensory nervous system in which pain stimuli occur spontaneously or as pathologically amplified responses. In this scenario, the exchange of signaling molecules throughout cell-to-cell and cell-to-extracellular environment communications plays a key role in the transition from acute to chronic pain. As such, connexin 43 (Cx43), the core glial gap junction and hemichannel-forming protein, is considered a triggering factor for disease chronicization in the central nervous system (CNS). Drugs targeting μ opioid receptors (MOR) are currently used for moderate to severe pain conditions, but their use in chronic pain is limited by the tolerability profile. δ opioid receptors (DOR) have become attractive targets for the treatment of persistent pain and have been associated with the inhibition of pain-sustaining factors. Moreover, it has been shown that simultaneous targeting of MOR and DOR leads to an improved pharmacological fingerprint. Herein, we aimed to study the effects of the benzomorphan ligand LP2, a multitarget MOR/DOR agonist, in an experimental model of neuropathic pain induced by the unilateral sciatic nerve chronic constriction injury (CCI) on male Sprague-Dawley rats. Results showed that LP2 significantly ameliorated mechanical allodynia from the early phase of treatment up to 21 days post-ligatures. We additionally showed that LP2 prevented CCI-induced Cx43 alterations and pro-apoptotic signaling in the CNS. These findings increase the knowledge of neuropathic pain development and the role of spinal astrocytic Cx43, suggesting new approaches for the treatment of neuropathic pain.

Original languageEnglish
JournalMolecular Neurobiology
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Connexin 43
delta Opioid Receptor
mu Opioid Receptor
Hyperalgesia
Neuralgia
Animal Models
Pain
Opioid Receptors
Constriction
Chronic Pain
Benzomorphans
Central Nervous System
Gap Junctions
Wounds and Injuries
Dermatoglyphics
Sciatic Nerve
Drug Delivery Systems
Neuroglia
Nervous System
Ligation

Keywords

  • Astrocytes
  • Chronic constriction injury
  • Gap junction
  • LP2
  • Spinal cord

ASJC Scopus subject areas

  • Neuroscience (miscellaneous)
  • Neurology
  • Cellular and Molecular Neuroscience

Cite this

Simultaneous Activation of Mu and Delta Opioid Receptors Reduces Allodynia and Astrocytic Connexin 43 in an Animal Model of Neuropathic Pain. / Vicario, Nunzio; Pasquinucci, Lorella; Spitale, Federica M.; Chiechio, Santina; Turnaturi, Rita; Caraci, Filippo; Tibullo, Daniele; Avola, Roberto; Gulino, Rosario; Parenti, Rosalba; Parenti, Carmela.

In: Molecular Neurobiology, 01.01.2019.

Research output: Contribution to journalArticle

Vicario, Nunzio ; Pasquinucci, Lorella ; Spitale, Federica M. ; Chiechio, Santina ; Turnaturi, Rita ; Caraci, Filippo ; Tibullo, Daniele ; Avola, Roberto ; Gulino, Rosario ; Parenti, Rosalba ; Parenti, Carmela. / Simultaneous Activation of Mu and Delta Opioid Receptors Reduces Allodynia and Astrocytic Connexin 43 in an Animal Model of Neuropathic Pain. In: Molecular Neurobiology. 2019.
@article{4226582398b04d418a300d13b92f6ad3,
title = "Simultaneous Activation of Mu and Delta Opioid Receptors Reduces Allodynia and Astrocytic Connexin 43 in an Animal Model of Neuropathic Pain",
abstract = "Neuropathic pain is a chronic condition triggered by lesions to the somatosensory nervous system in which pain stimuli occur spontaneously or as pathologically amplified responses. In this scenario, the exchange of signaling molecules throughout cell-to-cell and cell-to-extracellular environment communications plays a key role in the transition from acute to chronic pain. As such, connexin 43 (Cx43), the core glial gap junction and hemichannel-forming protein, is considered a triggering factor for disease chronicization in the central nervous system (CNS). Drugs targeting μ opioid receptors (MOR) are currently used for moderate to severe pain conditions, but their use in chronic pain is limited by the tolerability profile. δ opioid receptors (DOR) have become attractive targets for the treatment of persistent pain and have been associated with the inhibition of pain-sustaining factors. Moreover, it has been shown that simultaneous targeting of MOR and DOR leads to an improved pharmacological fingerprint. Herein, we aimed to study the effects of the benzomorphan ligand LP2, a multitarget MOR/DOR agonist, in an experimental model of neuropathic pain induced by the unilateral sciatic nerve chronic constriction injury (CCI) on male Sprague-Dawley rats. Results showed that LP2 significantly ameliorated mechanical allodynia from the early phase of treatment up to 21 days post-ligatures. We additionally showed that LP2 prevented CCI-induced Cx43 alterations and pro-apoptotic signaling in the CNS. These findings increase the knowledge of neuropathic pain development and the role of spinal astrocytic Cx43, suggesting new approaches for the treatment of neuropathic pain.",
keywords = "Astrocytes, Chronic constriction injury, Gap junction, LP2, Spinal cord",
author = "Nunzio Vicario and Lorella Pasquinucci and Spitale, {Federica M.} and Santina Chiechio and Rita Turnaturi and Filippo Caraci and Daniele Tibullo and Roberto Avola and Rosario Gulino and Rosalba Parenti and Carmela Parenti",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/s12035-019-1607-1",
language = "English",
journal = "Molecular Neurobiology",
issn = "0893-7648",
publisher = "Humana Press Inc.",

}

TY - JOUR

T1 - Simultaneous Activation of Mu and Delta Opioid Receptors Reduces Allodynia and Astrocytic Connexin 43 in an Animal Model of Neuropathic Pain

AU - Vicario, Nunzio

AU - Pasquinucci, Lorella

AU - Spitale, Federica M.

AU - Chiechio, Santina

AU - Turnaturi, Rita

AU - Caraci, Filippo

AU - Tibullo, Daniele

AU - Avola, Roberto

AU - Gulino, Rosario

AU - Parenti, Rosalba

AU - Parenti, Carmela

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Neuropathic pain is a chronic condition triggered by lesions to the somatosensory nervous system in which pain stimuli occur spontaneously or as pathologically amplified responses. In this scenario, the exchange of signaling molecules throughout cell-to-cell and cell-to-extracellular environment communications plays a key role in the transition from acute to chronic pain. As such, connexin 43 (Cx43), the core glial gap junction and hemichannel-forming protein, is considered a triggering factor for disease chronicization in the central nervous system (CNS). Drugs targeting μ opioid receptors (MOR) are currently used for moderate to severe pain conditions, but their use in chronic pain is limited by the tolerability profile. δ opioid receptors (DOR) have become attractive targets for the treatment of persistent pain and have been associated with the inhibition of pain-sustaining factors. Moreover, it has been shown that simultaneous targeting of MOR and DOR leads to an improved pharmacological fingerprint. Herein, we aimed to study the effects of the benzomorphan ligand LP2, a multitarget MOR/DOR agonist, in an experimental model of neuropathic pain induced by the unilateral sciatic nerve chronic constriction injury (CCI) on male Sprague-Dawley rats. Results showed that LP2 significantly ameliorated mechanical allodynia from the early phase of treatment up to 21 days post-ligatures. We additionally showed that LP2 prevented CCI-induced Cx43 alterations and pro-apoptotic signaling in the CNS. These findings increase the knowledge of neuropathic pain development and the role of spinal astrocytic Cx43, suggesting new approaches for the treatment of neuropathic pain.

AB - Neuropathic pain is a chronic condition triggered by lesions to the somatosensory nervous system in which pain stimuli occur spontaneously or as pathologically amplified responses. In this scenario, the exchange of signaling molecules throughout cell-to-cell and cell-to-extracellular environment communications plays a key role in the transition from acute to chronic pain. As such, connexin 43 (Cx43), the core glial gap junction and hemichannel-forming protein, is considered a triggering factor for disease chronicization in the central nervous system (CNS). Drugs targeting μ opioid receptors (MOR) are currently used for moderate to severe pain conditions, but their use in chronic pain is limited by the tolerability profile. δ opioid receptors (DOR) have become attractive targets for the treatment of persistent pain and have been associated with the inhibition of pain-sustaining factors. Moreover, it has been shown that simultaneous targeting of MOR and DOR leads to an improved pharmacological fingerprint. Herein, we aimed to study the effects of the benzomorphan ligand LP2, a multitarget MOR/DOR agonist, in an experimental model of neuropathic pain induced by the unilateral sciatic nerve chronic constriction injury (CCI) on male Sprague-Dawley rats. Results showed that LP2 significantly ameliorated mechanical allodynia from the early phase of treatment up to 21 days post-ligatures. We additionally showed that LP2 prevented CCI-induced Cx43 alterations and pro-apoptotic signaling in the CNS. These findings increase the knowledge of neuropathic pain development and the role of spinal astrocytic Cx43, suggesting new approaches for the treatment of neuropathic pain.

KW - Astrocytes

KW - Chronic constriction injury

KW - Gap junction

KW - LP2

KW - Spinal cord

UR - http://www.scopus.com/inward/record.url?scp=85064921554&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064921554&partnerID=8YFLogxK

U2 - 10.1007/s12035-019-1607-1

DO - 10.1007/s12035-019-1607-1

M3 - Article

AN - SCOPUS:85064921554

JO - Molecular Neurobiology

JF - Molecular Neurobiology

SN - 0893-7648

ER -